HOME Intervention for Postpartum Health

(HOME Trial)

MB
MM
AM
Overseen ByAngelina Malenda
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve postpartum care for women who may face challenges after giving birth, focusing on reducing unnecessary emergency department visits and ensuring access to needed services. Participants will be divided into two groups: one will receive a helpful pamphlet and support from a patient navigator as part of the HOME Discharge Planning Intervention, while the other will receive standard care. The trial seeks postpartum women who have delivered at the Hospital of the University of Pennsylvania, identify as Black, speak English, and meet other risk factors. This initiative supports new mothers in managing health conditions like hypertension, diabetes, and depression. As an unphased trial, it offers participants the opportunity to contribute to innovative postpartum care solutions that could benefit future mothers.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this educational intervention is safe for postpartum women?

Research has shown that education programs can improve care for new mothers after childbirth. One study on postpartum nursing programs found that they ease the transition from hospital to home. These programs provide essential medical advice and emotional support, helping mothers feel safer and more prepared after leaving the hospital.

Another review emphasizes the importance of education at discharge. It covers crucial safety topics like preventing falls, reducing infections, and recognizing postpartum depression. These programs ensure new mothers know when and how to seek help, teaching them to notice warning signs and act quickly.

In this trial, the HOME intervention provides new mothers with a pamphlet and access to a patient navigator, similar to the programs in the studies mentioned. The goal is to help mothers manage their health and connect them with useful resources. No harm or safety issues have been reported with these types of programs. Participants generally find them well-received and helpful.12345

Why are researchers excited about this trial?

Researchers are excited about the HOME intervention for postpartum health because it offers a comprehensive and proactive approach to managing postpartum conditions like hypertension, diabetes, and depression. Unlike standard postpartum care, which typically involves routine check-ups and addressing issues as they arise, the HOME intervention provides tailored education through pamphlets and partner sheets, empowering new mothers with self-management skills and enhanced social support. Moreover, the involvement of a patient navigator who maintains regular contact with participants ensures ongoing support and connection to resources, which can significantly improve postpartum outcomes. This personalized and continuous support system sets the HOME intervention apart from typical postpartum care practices.

What evidence suggests that the HOME intervention is effective for improving postpartum care?

Studies show that postpartum care should be ongoing and personalized for each woman. Research indicates that good planning and education upon hospital discharge can improve health by connecting new mothers with the right resources and support. One study found that postpartum clinics focusing on issues like high blood pressure and offering lifestyle advice proved helpful. Although some research suggests that a single educational session might not reduce depression, ongoing support and personalized care can address various postpartum challenges. In this trial, one group will receive a patient education pamphlet and partner sheet, along with support from a patient navigator to provide comprehensive resources and fill gaps in care. Another group will receive standard postpartum care. This approach aims to provide essential support during the important postpartum period.34678

Are You a Good Fit for This Trial?

This trial is for postpartum Black women aged 18 or older who have recently delivered at the Hospital of University of Pennsylvania. Participants must speak English, be able to read, and meet certain risk criteria as determined by a prediction model.

Inclusion Criteria

Self-identify as Black (listed on chart)
Postpartum patients who have delivered a baby at the Hospital of University of Pennsylvania
Other characteristics defined by our risk prediction model (algorithm)
See 1 more

Exclusion Criteria

Speaks a language other than English
I am unable to understand and give consent for treatment.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a patient education pamphlet and partner sheet, and are supported by a patient navigator for 30 days postpartum

4 weeks
4-20 contacts (phone/text)

Follow-up

Participants are monitored for safety and effectiveness after treatment, focusing on ED visits and readmissions

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • HOME
Trial Overview The study aims to reduce emergency department visits/readmissions within the first 30 days after childbirth. It tests whether providing a pamphlet and access to a patient navigator can improve postpartum care quality and service accessibility for high-risk individuals.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Patient Education Pamphlet and Partner SheetExperimental Treatment1 Intervention
Group II: Standard Postpartum CareActive Control1 Intervention

HOME is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as HOME for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

A randomized controlled trial involving 200 low-risk Iranian mothers showed that home-based postpartum care provided by midwives significantly improved maternal healthy behaviors compared to routine care, with a notable increase in mean scores from 120.5 to 148.9 in the intervention group.
The study found that many mothers in the control group did not receive their postpartum care, highlighting the effectiveness of home visits in ensuring mothers receive necessary support and care after delivery.
Comparison of effects of home visits and routine postpartum care on the healthy behaviors of Iranian low-risk mothers.Mirmolaei, ST., Valizadeh, MA., Mahmoodi, M., et al.[2022]
Midwives reported both positive and negative experiences with the shift from hospital to home-based postpartum care, highlighting the need for clearer leadership and better resource allocation during this transition.
The change was associated with increased continuity of care and professional growth for midwives, suggesting that while the transition has challenges, it also offers opportunities for improvement in care quality and job satisfaction.
Midwives' experiences of an organizational change in early postpartum care services in Norway: A qualitative study.Levorstad, T., Saue, MS., Nilsen, ABV., et al.[2022]
The SAFER Care framework, which includes standardized written and verbal discharge counseling, significantly improved caregiver comprehension of discharge instructions from 37% to 62% after implementation, based on surveys from 433 caregivers.
This study highlights the effectiveness of structured discharge counseling in a pediatric inpatient setting, suggesting that similar approaches could benefit other patient populations, especially those with limited English proficiency.
SAFER Care: Improving Caregiver Comprehension of Discharge Instructions.Uong, A., Philips, K., Hametz, P., et al.[2022]

Citations

Scoping Review of Postpartum Discharge Education ...Objective: To determine what is known about postpartum education provided by nurses to women before discharge from the hospital after birth and whether current ...
Effectiveness of Discharge Education on Postpartum ...Postpartum nursing discharge education did not decrease depression symptoms up to 6 months after discharge.
Optimizing Postpartum CarePostpartum care should become an ongoing process, rather than a single encounter, with services and support tailored to each woman's individual needs.
Advances in postpartum hypertension managementPostpartum hypertension clinics providing cardiovascular assessment, lifestyle counseling, and medication management have emerged as one such ...
Postpartum Discharge Transition Change PackageShare data on postpartum visit attendance with hospital systems where patients deliver and identify strategies to improve referral and scheduling processes.
innovative and comprehensive support for new mothersThe Healthy & Home postpartum community nursing program provides clinical communication and supports to bridge the gap between acute hospital and community ...
Patient Safety Bundles For Safer Birth | AIMPatient safety bundles are collections of evidence-informed best practices, developed by multidisciplinary experts, which address clinically specific conditions ...
Strategy 4: Care Transitions From Hospital to Home: IDEAL ...Research shows that when patients are engaged in their health care, it can lead to measurable improvements in safety and quality.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security